Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

MUSTANG BIO, INC.

CIK 1680048 MBIO·Pharmaceutical Preparations · All EDGAR filings ↗

Going concern Filing comparison

MUSTANG BIO, INC. no longer discloses a going-concern conclusion

Substantial doubt about ability to continue as a going concern No going-concern disclosure

As of December 31, 2025, we had an accumulated deficit of $398.6 million and cash and cash equivalents of $17.3 million. We have previously disclosed in our financial statements for the year ended December 31, 2024, and our most recent quarterly report on Form 10-Q for the period ended September 30, 2025, that substantial doubt existed regarding our ability to continue as a going concern. Although we have a history of negative cash flows from operations and operating losses, we have raised approximately $14.5 million in net proceeds from the February 2025 Equity Offering, the ATM Agreement…
Evidence
Blank check
No
Comparable
Yes
Current state
none
Current state label
No going-concern disclosure
Direction
eased
Located in
filing body
Prior filed
2025-03-28
Prior form
10-K
Prior state
substantial_doubt
Prior state label
Substantial doubt about ability to continue as a going concern
Source
ASC 205-40 going-concern note comparison
Why
Disclosure about the company's ability to continue as a going concern changed compared with its previous report.